Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Validation of the PsASon ULtrasound scores in patients with psoriatic arthritis undergoing TReatment with Apremilast

Next Previous
Search
Trial Profile

Validation of the PsASon ULtrasound scores in patients with psoriatic arthritis undergoing TReatment with Apremilast

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Apremilast (Primary)
  • Indications Psoriatic arthritis
  • Focus Diagnostic use; Therapeutic Use
  • Acronyms PSA-ULTRA

    • Most Recent Events

    • 30 Jul 2022 This trial has been discontinued in Austria, according to European Clinical Trials Database record.
    • 11 May 2021 Status changed from recruiting to discontinued as funding stopped.
    • 01 Sep 2020 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top